Search research articles
Contact Us
Filters
Showing results (121-130 of 143) with videos related to
Page
of 15
Sort By:
Leukemia & Lymphoma
|
February 21, 2022
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide
Craig W Freyer, Alison Carulli, Shannon Gier, et al.
Transplantation and Cellular Therapy
|
November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies
Matthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
P Bigot, J Bernhard, G Verhoest, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
P Bigot, J Bernhard, I Gill, et al.
Blood Advances
|
May 4, 2022
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia
Andrew H Matthews, Alexander E Perl, Selina M Luger, et al.
American Journal of Hematology
|
June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
Andrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Food & Function
|
April 23, 2025
Extended recommendations on the nomenclature for microbial catabolites of dietary (poly)phenols, with a focus on isomers
Claudio Curti, Michael N Clifford, Colin D Kay, et al.
Nature Medicine
|
October 3, 2018
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Marco Ruella, Jun Xu, David M Barrett, et al.
Transplantation and Cellular Therapy
|
January 19, 2024
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients
Anthony D Sung, Thuy Koll, Shannon H Gier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
January 15, 2018
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR
B Reix, J-C Bernhard, J-J Patard, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 143) with videos related to
Sort By:
Page
of 15
Leukemia & Lymphoma
|
February 21, 2022
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide
Craig W Freyer, Alison Carulli, Shannon Gier, et al.
Transplantation and Cellular Therapy
|
November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies
Matthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
P Bigot, J Bernhard, G Verhoest, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
P Bigot, J Bernhard, I Gill, et al.
Blood Advances
|
May 4, 2022
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia
Andrew H Matthews, Alexander E Perl, Selina M Luger, et al.
American Journal of Hematology
|
June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
Andrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Food & Function
|
April 23, 2025
Extended recommendations on the nomenclature for microbial catabolites of dietary (poly)phenols, with a focus on isomers
Claudio Curti, Michael N Clifford, Colin D Kay, et al.
Nature Medicine
|
October 3, 2018
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Marco Ruella, Jun Xu, David M Barrett, et al.
Transplantation and Cellular Therapy
|
January 19, 2024
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients
Anthony D Sung, Thuy Koll, Shannon H Gier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
January 15, 2018
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR
B Reix, J-C Bernhard, J-J Patard, et al.
Page
of 15